APIs

Product USDMF CEP EDMF C-DMF CA-DIF KDMF RUSSIA ANVISA BRAZIL Therapeutic Use
Aripiprazole √√√√ Antipsychotic agent
Articaine Hcl √√√ Anaesthetic
Atomoxetine Hcl √√√√√** ADHD therapeutic agent
Baclofen *√√*√√ Skeletal muscle relaxant
Benserazide √√ Anti-Parkinsonian agent
Betahistine DiHcl √√√*√* Anti-vertigo agent
Buspirone √√ Anti-anxiety
Calcium Acetate √ Phosphate binder
Cilostazol * Antiplatelet agent
Dabigatran Etexilate Mesylate * Anticoagulant
Dapagliflozin Propanediol Monohydrate ***√* Antidiabetic
Desvenlafaxine * Antidepressant
Dexmethylphenidate Hcl ADHD therapeutic agent
Diflunisal √√ NSAID agent
Dipyridamole √√√√ Antiplatelet
Doxazosin Mesylate √√√√√ Antihypertensive
Drotaverine Hcl √√√ Antispasmodic
Edoxaban Anticoagulant
Entacapone √√√√√√ Anti-parkinsonian agent
Epinastine Antihistamine agent
Fenoprofen √ NSAID
Flurbiprofen √√√ NSAID
Fluvoxamine Maleate √√√√* Antidepressant
Glycopyrrolate √√ Anticholinergic agent
Hydralazine Hcl √* Antihypertensive
Hydroxyzine Pamoate * Antihistamine
Irinotecan HCl Trihydrate *√ Oncology
Isosulfan Blue √ Diagnostic dye
L-Carglumic Acid √ Ammonia detoxicants
Lamotrigine *√√√√√√ Antiepileptic agent
Levodropropizine √√ Antitussive agent
Levomepromazine Maleate √√ Antipsychotic
Lercanidipine * Antihypertensive
Lisdexamfetamine dimesylate ** ADHD
Lurasidone Hcl * Antipsychotic
Maraviroc √ HIV CCR5 antagonist
Mebeverine HCl √√√√√ Antispasmodic
Methylphenidate Hcl √√*√ ADHD therapeutic agent
Midazolam √√√√√√√ Sedative/ Anaesthetic
Oxolamine Citrate Antitussive agent
Oxolamine Phosphate Antitussive agent
Oxymetazoline * Nasal decongestant
Pinaverium Bromide ** Antispasmodic agent
Pirfenidone √√√√√ Anti-inflammatory, antifibrotic
Posaconazole √ Antifungal agent
Probenecid √ Uricosuric agent
Propafenone Antiarrhythmic agent
Pyridostigmine Bromide ** Cholinesterase inhibitor
Quetiapine Fumarate √√√√√√√ Antipsychotic agent
Ractopamine HCl *√* Animal feed additive
Rivaroxaban √√√√√√√* Anticoagulant
Safinamide Anti-parkinsonian agent
Sulfasalazine * Anti-inflammatory agent
Tamsulosin Hcl √√√√√√√ Benign prostatic hyperplasia therapeutic agent
Tapentadol Phosphate * Analgesic
Tapentadol HCl * Analgesic
Trientine √ Copper chelating agent
Trimebutine *√ Gastroprokinetic agent
Trimetazidine dihydrochloride √** Anti-anginal agent
Venlafaxine Hcl *√** Antidepressant
Zilpaterol Animal feed additive
Zonisamide *√√√ Anticonvulsant

√ Available / Approved   * Filed / Awaiting Approval   ** To be Filed

Product Therapeutic Use Development Status
Acotiamide Anti-Dyspepsia agent Validation Completed
Apixaban Anticoagulant Validation Completed
Dexlansoprazole Sesquihydrate Proton Pump Inhibitor Under Validation
Erdosteine Mucolytic Agent Validation Completed
Indapamide Antihypertensive Under Validation
Isotretinoin Anti-acne Agent Under Optimization
Loxoprofen Non-Steroidal Anti-Inflammatory agent Validation Completed
Nintedanib Esylate Anti-inflammatory, Antifibrotic Under Validation
Remimazolam Besylate (Intermediate) Sedative, General Anaesthetic Validation Completed
Tegoprazan Anti-Ulcer Agent Under Optimization
Flurbiprofen (new route) Non-Steroidal Anti-Inflammatory agent Under Optimization
Vonoprazan Fumarate Anti-Ulcer Agent Under Optimization
Viloxazine HCl ADHD Therapeutic Agent Under Optimization
Trimebutine Base Gastroprokinetic Agent Under Validation
Clotrimazole Antifungal Agent Under Optimization
Doxylamine Antihistamine Under Optimization
Prazosin Antihypertensive Under Optimization
Alfuzosin BPH Therapeutic Agent Under Optimization
Terazosin BPH Therapeutic Agent, Antihypertensive Under Optimization
Serdexmethylphenidate Int. (SDS) CNS Stimulant Lab Validation
Serdexmethylphenidate Int. (SDP) CNS Stimulant Lab Validation

Pellets

Product DMF / Tech Pack Bioequivalence Established Type of BE Study RLD / Market Stability Brazil Turkey Mexico MENA APAC
Duloxetine HCl Delayed Release Pellets 20% (HPMC Acetyl Succinate) DMF Yes Fasting & Fed CYMBALTA / EU Available -36 M Yes Yes Yes Yes Yes
Duloxetine HCl Delayed Release Pellets 20% (HPMC Phthalate) DMF / Tech Pack Yes Fasting & Fed CYMBALTA / Turkey / EU Available -36 M No No No No Yes
Duloxetine Delayed Release Pellets 17% (HPMC Phthalate) DMF / Tech Pack No No – Available -12 M Yes No No Yes Yes
Itraconazole Immediate Release Pellets 21.74% DMF Yes Fasting & Fed SPORANOX / US Available -36 M No No Yes No Yes
Itraconazole Immediate Release Pellets 22% DMF No No – Available -36 M Yes No Yes Yes Yes
Venlafaxine HCl Extended Release Pellets 33% Dossier / DMF Yes Fasting & Fed EFFEXOR / EU Available -36 M Yes Yes Yes Yes Yes
Omeprazole Delayed Release Pellets 8.5% (LD-30) Dossier / DMF No No Available -36 M No No Yes Yes Yes
Omeprazole Delayed Release Pellets 8.5% (Phthalate) Dossier / DMF Yes Fasting & Fed Customer Established BE in Indonesia Available -36 M No No Yes Yes Yes
Tamsulosin Modified Release Pellets 0.12% Dossier Yes Fasting & Fed FLOMAX / US, SANDOZ / CANADA Available -6 M No No No Yes No
Tamsulosin HCl Modified Release Pellets 0.2% DMF No No FLOMAX / US Available -36 M Yes Yes Yes Yes Yes
Mebeverine HCl Sustained Release Pellets 80% DMF Yes Fasting & Fed & MDD / SS Colofac Retard 200 mg / EU Available -36 M Yes Yes No Yes Yes
Fenofibrate Sustained Release Pellets 75% DMF No No No Available -36 M Yes No No Yes No
Orlistat Immediate Release Pellets 50% (Extrudes) DMF No No Xenical / EU Available -36 M Yes No Yes Yes Yes
Lansoprazole Delayed Release Pellets 8.5% DMF Yes Fasting & Fed AGOPTON / EU Available -36 M Yes Yes Yes Yes Yes
Methylphenidate HCl Extended Release Pellets 11% DMF / Tech Pack Yes Fasting & Fed RITALIN LA / BR Available -12 M Yes No No No No
Methylphenidate HCl Immediate Release Pellets 11% DMF / Tech Pack Yes Fasting & Fed RITALIN LA / BR Available -12 M Yes No No No No
Product Name DMF / Tech Pack Bioequivalence Established Type of BE Study RLD / Mkt Stability Brazil Turkey Mexico MENA APAC
Duloxetine Hydrochloride Delayed Release Pellets 17% Tech Pack No No No 6M data available – – – – –
Trimetazidine Extended Release Pellets 55% Tech Pack No No VASTAREL MR / Brazil 6M data available Yes – – – –
Dabigatran Etexilate Pellets 35% Tech Pack No Fast Single Dose Study PRADAXA / US 3M data available – – – Yes –

Finished Dosage Forms

Product Strength ANDA (Approved/Filed) EU Dossier (Approved/Filed) ANDS (Approved/Filed) Countries for which Dossier are available
Baclofen Tablets 5mg Approved Not Filed Except USA
Baclofen Tablets 10mg Approved Not Filed Except USA
Baclofen Tablets 20mg Approved Not Filed Except USA
Cinacalcet tablets 30 mg Approved Approved Can be offered globally
Cinacalcet tablets 60 mg Approved Approved Can be offered globally
Cinacalcet tablets 90 mg Approved Approved Can be offered globally
Doxazosin tablets 1 mg Filed Not filed Approved in CA Except USA, Canada
Doxazosin tablets 2 mg Filed Not filed Approved in CA Except USA, Canada

Show More

Product Strength Status
FERRIC CITRATE Tablets EQ210 IRON Proof of concept established
Aspirin+Dipyridamole ER Capsules 25/200mg Proof of concept established
Mexiletine Capsules 150mg/200mg/250mg Proof of concept established
Diflunisal tablets 500 mg Proof of concept established
Dipyridamole ER capsules 200 mg Proof of concept established
Solifenacin & Tamsulosin PR tablets 6 mg/0.4 mg Proof of concept established
Hydralazine HCl tablets 10 mg, 25 mg, 50 mg   and 100 mg Proof of concept established
Tamsulosin MR tablets 0.4mg Under development

Show More

Your API deserves more than a manufacturer. It deserves a partner.